Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The chimeric BCR-ABL gene

J Groffen1, N Heisterkamp

  • 1Department of Pathology, Childrens Hospital of Los Angeles Research Institute, CA 90027, USA.

Bailliere'S Clinical Haematology
|June 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parasite Infections Influence Immunological Responses But Not Reproductive Success of Male Hellbender Salamanders (<i>Cryptobranchus alleganiensis</i>).

Integrative organismal biology (Oxford, England)·2025
Same author

Modulation of Paternal Care Behaviors in Response to Stream Conditions by Eastern Hellbenders (<i>Cryptobranchus alleganiensis alleganiensis</i>).

Integrative organismal biology (Oxford, England)·2025
Same author

Cytotoxicity of CD56-positive lymphocytes against autologous B-cell precursor acute lymphoblastic leukemia cells.

Leukemia·2014
Same author

Galectin-3 in pre-B acute lymphoblastic leukemia.

Leukemia·2013
Same author

AMD3100 sensitizes acute lymphoblastic leukemia cells to chemotherapy in vivo.

Blood cancer journal·2012
Same author

Treatment of acute lymphoblastic leukemia with an rGel/BLyS fusion toxin.

Leukemia·2012
Same journal

Current status of stem cell therapy and prospects for gene therapy for the disorders of globin synthesis.

Bailliere's clinical haematology·2000
Same journal

Pharmacological therapy.

Bailliere's clinical haematology·2000
Same journal

Prenatal diagnosis and screening of the haemoglobinopathies.

Bailliere's clinical haematology·2000
Same journal

Sickle cell disease: clinical management.

Bailliere's clinical haematology·2000
Same journal

Pathophysiology of sickle cell disease.

Bailliere's clinical haematology·2000
Same journal

Thalassaemia: clinical management.

Bailliere's clinical haematology·2000
See all related articles

The discovery of the BCR-ABL fusion in chronic myeloid leukemia (CML) spurred research into gene function. However, the exact cause of BCR-ABL fusion and CML progression remains unknown.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • The 1982 discovery identified the BCR-ABL fusion gene in chronic myeloid leukemia (CML).
  • The complete nucleotide sequences of BCR and significant portions of ABL are now known.
  • The underlying cause of BCR-ABL gene fusion remains largely unexplained.

Purpose of the Study:

  • To investigate the structural organization and function of BCR and ABL genes.
  • To understand the mechanisms behind BCR-ABL fusion and its role in CML.
  • To explore the causes of CML disease progression and the blast phase.

Main Methods:

  • Analysis of gene sequences for BCR and ABL.
  • Utilizing mouse models to study gene function and protein activity.
  • Investigating signal transduction pathways and cell cycle control.

Related Experiment Videos

Main Results:

  • The nucleotide sequences of BCR and major parts of ABL have been determined.
  • Mouse models have provided insights into the normal functions of BCR and ABL, and the activity of BCR-ABL.
  • A single, unifying mechanism for the transforming activity of BCR-ABL has not been identified.
  • No specific genetic abnormality has been definitively linked to the blast phase of CML.

Conclusions:

  • Significant advancements have been made in understanding the molecular biology of CML.
  • Fundamental questions regarding the cause of BCR-ABL fusion and CML progression are still under investigation.
  • Future research, leveraging knowledge of genome structure and cellular processes, is expected to yield answers.